Acylgalactosylceramides in developing dysmyelinating mutant mice.
Acylgalactosylceramides (AGC) from forebrains of normal and dysmyelinating (quaking and shiverer) mice were purified by Florisil column chromatography and preparative TLC. These procedures resolved the AGC on the basis of their Rf values into two main fractions which comigrate with their homologs from rat forebrains. In control animals, AGC were detectable in mouse forebrains from the eighth postnatal day and reached maximal values within 20 days. The same developmental pattern was obtained in dysmyelinating shiverer mice but the AGC content was reduced to approximately 30% of control values. In quaking mutants, the AGC were hardly detected. They were also present in sciatic nerve of normal mice and to a lesser extent in trembler mice. Gas chromatography-mass spectrometry analysis of both ester- and amide-linked fatty acids isolated from AGC of normal and shiverer mice shows that the shiverer mutant AGC display a chemical structure similar to that of normal AGC. AGC constituents of control myelin are reduced by approximately 70% in shiverer myelin, indicating that these molecules can be considered as early markers of oligodendrocyte differentiation. The early arrest of myelinogenesis in the quaking animals and the near absence of AGC are in good agreement with this proposal. Moreover, the reduced amount of AGC in the trembler PNS indicates that AGC could also be early markers for differentiation of the Schwann cell.
Theret
N
N
SERLIA, Institut Pasteur, Lille, France.
Boulenguer
P
P
Fournet
B
B
Fruchart
J C
JC
Bourre
J M
JM
Delbart
C
C
D000818:Animals; D001921:Brain / Q000254:growth & development / Q000378:metabolism; D002518:Ceramides / Q000378:metabolism*; D051379:Mice; D008818:Mice, Neurologic Mutants / Q000254:growth & development / Q000378:metabolism*; D009186:Myelin Sheath / Q000378:metabolism* / Q000502:physiology; D012016:Reference Values; D012584:Sciatic Nerve / Q000254:growth & development / Q000378:metabolism
D002518:Ceramides